Mass spectrometric characterization of urinary fibrinogen-derived peptides in prostate cancer and renal cell carcinoma
In previous studies we have found that urinary fibrinogen-derived peptides are potential tumor markers for renal cell carcinoma. These peptides occur at low concentrations in urine. Identification of a low-abundant tumor marker requires optimal sample preparation and a highly sensitive analyzer. In...
Main Author: | |
---|---|
Format: | Dissertation |
Language: | English |
Published: |
University of Oulu
2015
|
Subjects: | |
Online Access: | http://urn.fi/URN:NBN:fi:oulu-201512082282 http://nbn-resolving.de/urn:nbn:fi:oulu-201512082282 |
id |
ndltd-oulo.fi-oai-oulu.fi-nbnfioulu-201512082282 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-oulo.fi-oai-oulu.fi-nbnfioulu-2015120822822018-06-22T04:51:11ZMass spectrometric characterization of urinary fibrinogen-derived peptides in prostate cancer and renal cell carcinomaMesihää, M. (Markus)info:eu-repo/semantics/openAccess© Markus Mesihää, 2015MDP in Protein Science and BiotechnologyIn previous studies we have found that urinary fibrinogen-derived peptides are potential tumor markers for renal cell carcinoma. These peptides occur at low concentrations in urine. Identification of a low-abundant tumor marker requires optimal sample preparation and a highly sensitive analyzer. In this work different chromatographic and mass spectrometric methods were compared and evaluated for tumor marker discovery. We used urine samples from patients with renal cell carcinoma and prostate cancer. Our main targets were peptides derived from fibrinogen beta with unknown sequence that are produced by differential proteolysis. With our optimized workflow we discovered 26 fibrinogen beta derived peptides that have not been identified in urine previously.University of Oulu2015-12-11info:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://urn.fi/URN:NBN:fi:oulu-201512082282urn:nbn:fi:oulu-201512082282eng |
collection |
NDLTD |
language |
English |
format |
Dissertation |
sources |
NDLTD |
topic |
MDP in Protein Science and Biotechnology |
spellingShingle |
MDP in Protein Science and Biotechnology Mesihää, M. (Markus) Mass spectrometric characterization of urinary fibrinogen-derived peptides in prostate cancer and renal cell carcinoma |
description |
In previous studies we have found that urinary fibrinogen-derived peptides are potential tumor markers for renal cell carcinoma. These peptides occur at low concentrations in urine.
Identification of a low-abundant tumor marker requires optimal sample preparation and a highly sensitive analyzer. In this work different chromatographic and mass spectrometric methods were compared and evaluated for tumor marker discovery. We used urine samples from patients with renal cell carcinoma and prostate cancer.
Our main targets were peptides derived from fibrinogen beta with unknown sequence that are produced by differential proteolysis. With our optimized workflow we discovered 26 fibrinogen beta derived peptides that have not been identified in urine previously. |
author |
Mesihää, M. (Markus) |
author_facet |
Mesihää, M. (Markus) |
author_sort |
Mesihää, M. (Markus) |
title |
Mass spectrometric characterization of urinary fibrinogen-derived peptides in prostate cancer and renal cell carcinoma |
title_short |
Mass spectrometric characterization of urinary fibrinogen-derived peptides in prostate cancer and renal cell carcinoma |
title_full |
Mass spectrometric characterization of urinary fibrinogen-derived peptides in prostate cancer and renal cell carcinoma |
title_fullStr |
Mass spectrometric characterization of urinary fibrinogen-derived peptides in prostate cancer and renal cell carcinoma |
title_full_unstemmed |
Mass spectrometric characterization of urinary fibrinogen-derived peptides in prostate cancer and renal cell carcinoma |
title_sort |
mass spectrometric characterization of urinary fibrinogen-derived peptides in prostate cancer and renal cell carcinoma |
publisher |
University of Oulu |
publishDate |
2015 |
url |
http://urn.fi/URN:NBN:fi:oulu-201512082282 http://nbn-resolving.de/urn:nbn:fi:oulu-201512082282 |
work_keys_str_mv |
AT mesihaammarkus massspectrometriccharacterizationofurinaryfibrinogenderivedpeptidesinprostatecancerandrenalcellcarcinoma |
_version_ |
1718702162242961408 |